Codexis, Inc. (CDXS) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Of the 6 companies Codexis, Inc. moves with most closely, none share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 2860, Industrial Organic Chemicals, from each company's own filings. Largest first.
the bull case· 3
148
managers reporting a position in thirteen F filings
13fJun 30 '26+0.27%
change in shares held by the ten largest reporting managers
13fJun 30 '263
of the funds on file reporting a position in CDXS
n-portas of Jun 30 '26the bear case· 3
51.00%
of revenue from the largest disclosed customer one customer
10-Kfiled Mar 11 '260.01%
of iShares Russell two thousand ETF's assets the largest fund weight on file
n-portJun 30 '267 of 23
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 5 '26 report. Not a forecast, not advice.
tall tick = annual report · 1 on record
147 managers report a position worth $146.7M between them, and 16 of them hold 80% of it.
CDXS (Codexis, Inc.) has 7 disclosed suppliers and 13 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 1.39 at 3:30 pm ET, low 1.32 at 10:15 am ET.
Codexis, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Industrial Organic Chemicals